How does dysfibrinogenemia affect the coagulation process, and what are its clinical implications?

A It leads to an increased risk of thrombosis due to enhanced fibrin formation
B It results in a bleeding tendency due to impaired fibrin clot formation
C It has no significant effect on coagulation, but may cause renal dysfunction
D It increases the risk of arterial thrombosis, but not venous thrombosis
Dysfibrinogenemia is a rare coagulation disorder characterized by the presence of abnormal fibrinogen, leading to impaired fibrin clot formation and a bleeding tendency.
Specialized hematology literature and case reports
Hematology Hematology: Coagulation Disorders Hematology: Coagulation Disorders Hard MEDICAL Confidence: medium